

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 2,257.66 | 1,929.06 | 1,707.63 | 1,410.45 | 1,030.39 |
| Total Expenses | 2,201.47 | 1,865.62 | 1,662.73 | 1,415.86 | 1,165.24 |
| Profit Before Tax | 56.96 | 67.73 | 44.88 | 87.77 | -228.66 |
| Profit After Tax | 48.83 | 41.33 | 17.63 | 38.92 | -221.10 |
| Operating Profit After Depreciation | 210.75 | 172.17 | 148.40 | 92.35 | -15.68 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 2,441.89 | 1,758.16 | 1,553 | 1,547.14 | 1,382.38 |
| Total Non Current Assets | 2,699.44 | 2,027.65 | 1,735.68 | 1,717.19 | 1,600.65 |
| Total Current Assets | 843.80 | 679.85 | 580.34 | 502.34 | 434.96 |
| Total Assets | 3,543.24 | 2,707.50 | 2,316.02 | 2,219.52 | 2,035.61 |
| Total Shareholder's Fund | 922.44 | 825.78 | 860.52 | 870.29 | 697.18 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 317.11 | 284.58 | 251.59 | 220.12 | 120.52 |
| Net Cash Used In Investing Activities | -487.75 | -225.73 | -133.03 | 124.59 | -171.10 |
| Net Cash Used In Financing Activities | -42.44 | -64.02 | -140.07 | -154.89 | 112.24 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,315.10 | 1,116.17 | 1,016.39 | 862.25 | 632.88 |
| Total Expenses | 1,260.70 | 1,045.21 | 955.77 | 834.12 | 684.84 |
| Profit Before Tax | 19.58 | 54.87 | 57.62 | 81.04 | -205.06 |
| Profit After Tax | 3.53 | 33.96 | 40.19 | 38.25 | -191.55 |
| Operating Profit After Depreciation | 138.54 | 118.93 | 102.11 | 70.92 | 10.90 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,038.05 | 938.08 | 787.63 | 773.84 | 745.17 |
| Total Non Current Assets | 1,963.35 | 1,674.82 | 1,357.19 | 1,287.46 | 1,246.52 |
| Total Current Assets | 640.45 | 513.07 | 372.52 | 356.16 | 327.99 |
| Total Assets | 2,603.80 | 2,187.89 | 1,729.71 | 1,643.62 | 1,574.51 |
| Total Shareholder's Fund | 1,191.32 | 1,188.59 | 1,145.12 | 1,097.69 | 923.78 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 145.95 | 208.89 | 130.40 | 124.40 | 70.89 |
| Net Cash Used In Investing Activities | -347.32 | -253.94 | -137.70 | 48.65 | -245.62 |
| Net Cash Used In Financing Activities | -41.55 | 95.92 | -41.71 | -41.04 | 235.92 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 652.33 | 633.07 | 646.85 | 613.16 | 585.16 |
| Total Expenses | 527.25 | 523.51 | 523.54 | 505.37 | 479.53 |
| Profit Before Tax | 1.25 | -6.07 | 19.82 | 11.92 | 13.62 |
| Profit After Tax | 4.04 | -7.90 | 20.66 | 5.98 | 6.77 |
| Operating Profit after Depreciation | 138.67 | 112.03 | 126.24 | 115.30 | 115.86 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 350.21 | 342.16 | 345.84 | 327.09 | 324.38 |
| Total Expenses | 275.07 | 287.86 | 283.54 | 277.24 | 265.49 |
| Profit Before Tax | -8.95 | -1.27 | 14.60 | 5.24 | 16.80 |
| Profit After Tax | 1.53 | -1.18 | 10.78 | 3.45 | 10.15 |
| Operating Profit after Depreciation | 90.06 | 57.29 | 66.12 | 57.79 | 68.35 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Apollo Hospitals Enterprise Ltd | ₹8,495.95 | ₹1,22,158.73 |
| Max Healthcare Institute Ltd | ₹1,008.95 | ₹98,195.43 |
| Fortis Healthcare Ltd | ₹988.95 | ₹74,661.59 |
| Aster DM Healthcare Ltd | ₹814.20 | ₹42,185.41 |
| Narayana Hrudayalaya Ltd | ₹1,861.80 | ₹38,047.89 |
| Fund Name | AUM |
|---|---|
| Tata India Pharma & Healthcare Fund | 5.87% |
| Motilal Oswal Consumption Fund | 5.47% |
| Motilal Oswal Business Cycle Fund | 4.13% |
| Tata Focused Fund | 3.64% |
| Motilal Oswal Multi Cap Fund | 2.95% |
HealthCare Global Enterprises has reported 70.5% drop in consolidated net profit to Rs 2.17 crore despite a 11.5% increase in revenue to Rs 650.29 crore in Q4 FY26 as compared with Q4 FY25.
20 May 2026, 01:14 pm
Equipped with world's most advanced precision radiation therapy platform
19 May 2026, 01:46 pm
On 19 May 2026
02 May 2026, 12:18 pm
On 24 February 2026
24 Feb 2026, 08:17 pm
On 24 February 2026
18 Feb 2026, 10:20 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.